Applied DNA Sciences, Inc.
APDN
$2.99
-$0.27-8.28%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -2.64M | -3.30M | -- |
| Total Depreciation and Amortization | -- | -- | 58.60K | 77.00K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -231.30K | 164.40K | -- |
| Change in Net Operating Assets | -- | -- | -513.90K | -193.70K | -- |
| Cash from Operations | -- | -3.19M | -3.33M | -3.25M | -3.49M |
| Capital Expenditure | -- | -- | -116.90K | -371.30K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -185.30K | -116.90K | -371.30K | -21.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 6.31M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -390.70K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 899.20K | 6.31M | -390.70K | 10.81M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -2.47M | 2.86M | -4.01M | 7.29M |